Labiana has completed the validation of the analytical methods for cannabis flowers intended for therapeutic use according to the European Pharmacopoeia. This allows the company to certify producers or distributors worldwide that their batches comply with the specifications required by current regulations.
Labiana ha hecho público su informe de resultados mostrando un incremento del 1,6% en su facturación en 2022. Apúntate al Webinar.